Sense Neuro Diagnostics has big plans for advancing the detection and continuous monitoring of traumatic brain injury (TBI), thanks to a $2.43 million contract from the U.S. Department of Defense.
Sense was selected for the contract by the U.S. Army Medical Research and Development Command (USAMRDC) Combat Casualty Care Research Program and the award was issued through Medical Technology Enterprise Consortium (MTEC), a biomedical technology consortium working to advance innovative medical solutions for military personnel.
“We believe Sense Neuro Diagnostics is well positioned to deliver on USAMRDC’s goals of improving outcomes for service members who suffer traumatic brain injury,” said Geoff Klass, CEO of Sense Neuro Diagnostics. “With rapid detection and continuous monitoring, our technology will enable proper triage and treatment when it matters most.”
TBI is a signature wound of recent wars, with roughly 420,000 documented incidents of service members sustaining at least one TBI in the last two decades. Proper diagnosis and treatment are critical in the 1-3 days following brain injury, but battlefield and far-forward operational conditions make evacuation difficult, potentially delaying diagnosis and vital care. There is currently no objective tool for diagnosing and monitoring TBI and brain hemorrhage in a field environment, with medical personnel instead relying on a patient questionnaire and the Glasgow Coma Scale to diagnose and stratify the severity of TBI.
Cincinnati, OH-based Sense is developing rapid, non-invasive brain scanners that use low-power tailored radio frequency pulse to detect TBI in seconds and, through continuous monitoring, indications of expanding brain hemorrhage. The scanners are small, flexible, and portable, designed to fit on a patient’s head like a cap. The technology was invented by Sense’s medical co-founders who are specialists in emergency medicine, neurology, and neurocritical care.
The MTEC award will fund the completion of product development and clinical testing over the next 18 months.